FindTrial
Sign In

To study the role of miasm in homoeopathic management of grade-I and grade-II hemorrhoids

To explore the role of miasms in homoeopathic management of grade-I and grade-II hemorrhoids in age group 25-60 years- A prospective case series study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/10/096273
Enrollment
30
Registered
2025-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Latika wagh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from grade I and grade II hemorrhoids presenting with any of the symptoms bleeding pain tenesmus heaviness pruritus mucus discharge from anorectal region 2.Diagnosed cases of hemorrhoids taking treatment from other system of medicine but feeling no relief and now willing to take homoeopathic treatment 3.Age group 25 To 60 years 4.Patients from various socioeconomic status 5.Patients with Hb count less than 8 gm per dl 6.Patients with signed written consent

Exclusion criteria

Exclusion criteria: 1.Patients suffering from grade III and grade IV hemorrhoids 2.Age group less than 25 years and more than 60 years 3.Patients with associated comorbidities like fissures fistula anal stricture and other systemic disorders like known bleeding disorders diabetes mellitus and hypertension 4.Patients with Hb count more than 8 gm per dl 5.Pregnant females

Design outcomes

Primary

MeasureTime frame
Visual analogue scale is used to measure the severity of hemorrhoid symptoms before and after treatment 1.Improved 2.Not improvedTimepoint: 1.Duration of study-18 months 2.Duration of each case- Each case will be studied for 6 months or till recovery occurs, whichever is earlier 3.Duration of follow up- As per requirement and severity of case 4.Clinical outcome assessment will be done at baseline of 3 months and 6 months—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactDr Ajay Dahad

Smt. K.B.Abad Homoeopathic medical college chandwad

shatrughantrpth4@gmail.com9765310371

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026